FREGA, STEFANO

FREGA, STEFANO  

Università di Padova  

Mostra records
Risultati 1 - 18 di 18 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts) 2021 Dal Maso, A.Ferro, A.Pretelli, G.Frega, S.Menis, J.Pasello, G.Guarneri, V.Conte, P. F.Bonanno, L. + JOURNAL OF THORACIC ONCOLOGY - -
1398P Real-life progression (PD) pattern of EGFR mutant advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving systemic therapy after first- or second-generation tyrosine kinase inhibitor (1-2 gen TKI) 2020 Dal Maso, A.Ferro, A.Lorenzi, M.Scattolin, D.Frega, S.Bonanno, L.Indraccolo, S.Calabrese, F.Guarneri, V.Conte, P. F.Pasello, G. + ANNALS OF ONCOLOGY - -
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW) 2021 Lorenzi, M.Dal Maso, A.Ferro, A.Scattolin, D.Indraccolo, S.Frega, S.Menis, J.Bonanno, L.Guarneri, V.Conte, P. F.Pasello, G. + JOURNAL OF THORACIC ONCOLOGY - -
166P: Non-small cell lung cancer (NSCLC) patients with rare or complex epidermal growth factor receptor (EGFR) mutations: A single institution series 2016 Pasello, GFREGA, STEFANOIndraccolo, SFASSAN, MATTEOBonanno, LCONTE, PIERFRANCOCALABRESE, FIORELLA + JOURNAL OF THORACIC ONCOLOGY - -
18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy 2019 Evangelista L.Cuppari L.Menis J.Bonanno L.Frega S.Pasello G. + NUCLEAR MEDICINE COMMUNICATIONS - -
A triple rare E709K and L833V/H835L EGFR mutation responsive to an irreversible pan-HER inhibitor: A case report of lung adenocarcinoma treated with afatinib 2016 FREGA, STEFANOCONTE, PIERFRANCOFASSAN, MATTEOPOLO, VALENTINAPASELLO, GIULIA JOURNAL OF THORACIC ONCOLOGY - -
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 2020 Dal Maso A.Lorenzi M.Urso L.Frega S.Bonanno L.Indraccolo S.Calabrese F.Conte P.Pasello G. + CLINICAL LUNG CANCER - -
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 2019 Pasello, GiuliaDal Maso, AlessandroLorenzi, MartinaScattolin, DanielaUrso, LoredanaZulato, ElisabettaFrega, StefanoBonanno, LauraIndraccolo, StefanoCalabrese, FiorellaConte, Pierfranco + JOURNAL OF CLINICAL ONCOLOGY - -
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations 2017 FREGA, STEFANOLorenzi, MartinaFASSAN, MATTEOIndraccolo, StefanoCALABRESE, FIORELLABonanno, LauraLunardi, FrancescaPAVAN, ALBERTORUGGE, MASSIMOGUARNERI, VALENTINAConte, PierfrancoPasello, Giulia + ONCOTARGET - -
Detection of loss of heterozygosity in cfDNA of advanced EGFR-or KRAS-mutated non-small-cell lung cancer patients 2020 Nardo G.Zulato E.Bonanno L.Frega S.Indraccolo S. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study) 2019 Pasello, GiuliaSanto, AntonioBonanno, LauraMenis, JessicaFrega, StefanoGuarneri, ValentinaConte, PierFranco + THE ONCOLOGIST - -
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 2021 Pasello G.Menis J.Pilotto S.Frega S.Pezzuto F.Sepulcri M.Schiavon M.Damin M.Del Bianco P.Giovannetti R.Bonanno L.Guarneri V.Calabrese F.Rea F.Milella M.Conte P. + FRONTIERS IN ONCOLOGY - -
Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature 2015 POLO, VALENTINAZAGO, GIULIAFREGA, STEFANOCANOVA, FABIOBonanno, LauraFAVARETTO, ADOLFOBERTORELLE, ROBERTACONTE, PIERFRANCOPASELLO, GIULIA + THE AMERICAN JOURNAL OF CASE REPORTS - -
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 2020 Zulato, ElisabettaFerro, AlessandraBoscolo, AliceAttili, IlariaFrega, StefanoDal Maso, AlessandroPasello, GiuliaGuarneri, ValentinaConte, Pier FrancoIndraccolo, StefanoBonanno, Laura + JOURNAL OF CLINICAL ONCOLOGY - -
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines 2021 Dal Maso, ALorenzi, MFerro, AScattolin, DIndraccolo, SFrega, SMenis, JBonanno, LCalabrese, FGuarneri, VConte, PPasello, G + FUTURE ONCOLOGY - -
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 2021 Boscolo Bragadin, AndreaZulato, ElisabettaAttili, IlariaDal Maso, AlessandroFrega, StefanoFassan, MatteoCalabrese, FiorellaPasello, GiuliaGuarneri, ValentinaConte, PierFrancoIndraccolo, StefanoBonanno, Laura + TRANSLATIONAL LUNG CANCER RESEARCH - -
Squamous cell carcinomas of the lung and of the head and neck: New insights on molecular characterization 2016 Pasello, GiuliaFrega, StefanoFavaretto, AdolfoConte, PierfrancoBONANNO, LAURA + ONCOTARGET - -
Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future? 2018 Frega, StefanoBonanno, LauraGuarneri, ValentinaConte, PierfrancoPasello, Giulia CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - -